Bristol-Myers Squibb Co (BMY)
43.99
+0.29
(+0.66%)
USD |
NYSE |
May 03, 16:00
43.97
-0.02
(-0.05%)
After-Hours: 20:00
Bristol-Myers Squibb Shareholders Equity (Quarterly): 16.49B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 16.49B |
December 31, 2023 | 29.43B |
September 30, 2023 | 29.00B |
June 30, 2023 | 31.97B |
March 31, 2023 | 31.82B |
December 31, 2022 | 31.06B |
September 30, 2022 | 32.67B |
June 30, 2022 | 32.60B |
March 31, 2022 | 31.58B |
December 31, 2021 | 35.95B |
September 30, 2021 | 37.21B |
June 30, 2021 | 36.81B |
March 31, 2021 | 37.60B |
December 31, 2020 | 37.82B |
September 30, 2020 | 50.16B |
June 30, 2020 | 49.09B |
March 31, 2020 | 49.91B |
December 31, 2019 | 51.60B |
September 30, 2019 | 17.65B |
June 30, 2019 | 16.05B |
March 31, 2019 | 15.22B |
December 31, 2018 | 14.03B |
September 30, 2018 | 13.64B |
June 30, 2018 | 12.32B |
March 31, 2018 | 12.79B |
Date | Value |
---|---|
December 31, 2017 | 11.74B |
September 30, 2017 | 14.78B |
June 30, 2017 | 14.70B |
March 31, 2017 | 14.42B |
December 31, 2016 | 16.18B |
September 30, 2016 | 15.61B |
June 30, 2016 | 14.92B |
March 31, 2016 | 14.39B |
December 31, 2015 | 14.27B |
September 30, 2015 | 15.08B |
June 30, 2015 | 15.12B |
March 31, 2015 | 15.55B |
December 31, 2014 | 14.85B |
September 30, 2014 | 15.14B |
June 30, 2014 | 15.33B |
March 31, 2014 | 15.47B |
December 31, 2013 | 15.15B |
September 30, 2013 | 14.73B |
June 30, 2013 | 14.37B |
March 31, 2013 | 13.66B |
December 31, 2012 | 13.62B |
September 30, 2012 | 13.90B |
June 30, 2012 | 16.10B |
March 31, 2012 | 16.34B |
December 31, 2011 | 15.96B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
16.05B
Minimum
Jun 2019
51.60B
Maximum
Dec 2019
34.32B
Average
32.64B
Median
Shareholders Equity (Quarterly) Benchmarks
Amgen Inc | 5.022B |
Gilead Sciences Inc | 17.46B |
Johnson & Johnson | 70.02B |
Karuna Therapeutics Inc (DELISTED) | 1.254B |
2seventy bio Inc | 255.30M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 99.03B |
Total Liabilities (Quarterly) | 82.48B |
Debt to Equity Ratio | 3.376 |
Current Ratio | 1.110 |
Net Debt Paydown Yield | -2.98% |